Skip to content

Educational reference only. Not medical advice, diagnosis, or treatment, and not dosing, injection, or purchasing guidance.Medical disclaimer

Glossary

One hundred terms used in the twelve domains. Where a gloss points at another page, that page holds the sourced sentence.

The substance intended to have a pharmacological effect in a finished drug, as distinct from excipients.

An untoward medical occurrence in a person using a product. It is not, by itself, proof the product caused it.

WHO uses this term for products that maintain or improve functioning. See the WHO page for the fact sheet.

A loose popular label for self-directed experiments on body, data, or biology. This wiki does not treat the label as a method.

A measured characteristic used as an indicator of a biological state. A wearable estimate is not automatically a validated biomarker.

A system that translates brain signals into commands for a computer or machine. Performance claims need a study.

A U.S. FDA device program. Eligibility and the specific device must be checked on an FDA record, which is not copied here.

FDA’s term for an active ingredient used in compounding. Listing status has to be read from the FDA page.

On FDA’s interim compounding lists, a category for nominated bulk substances FDA says may pose significant safety risks.

A manufacturer’s document reporting tests on a batch. It is not an independent regulatory approval.

Current good manufacturing practice. The exact regulatory text depends on the product type and was not pasted here.

The U.S. trial registry. A page on this wiki should cite an NCT record rather than summarize a trial from memory.

An implanted device the International Neuromodulation Society names as an example of restoring a sensory function.

A drug prepared by compounding. FDA says compounded drugs are not FDA-approved.

A device that tracks glucose over time. Accuracy and whether a given product is a medical device are not stated in this glossary.

Electrical stimulation through electrodes placed in deep brain targets. The neuromodulation page attributes examples to the INS.

A U.S. FDA pathway for novel devices. A classification decision has to be read from an FDA record.

Laboratory or community work done outside a conventional institution. This wiki does not describe how to do it.

Recording electrical activity of the brain from electrodes. EEG is the usual abbreviation.

Recording electrical activity from electrodes on the surface of the brain. Specifications are not given here.

Recording electrical activity from muscle. Prosthetic control uses of EMG are not instructed here.

A bacterial product that can contaminate injectable drugs. Numeric limits are not stated in this glossary.

A model that estimates age-related state from epigenetic measurements. No clock’s error is stated here.

This wiki’s A–E scale, from human randomized trials down to anecdote. Unrated means the design was not cited.

A wearable frame that supports or moves limbs. Device claims are not stated in this glossary.

An optical method for inferring brain blood-oxygen changes. fNIRS is the usual abbreviation.

An FDA policy area for low-risk products that promote a general state of health. The policy text was not pasted here.

Glucagon-like peptide-1. On this wiki the drug-class notes are limited to the FDA page linked from the GLP-1 article.

Glucose-dependent insulinotropic polypeptide. This glossary does not assign drugs to this target.

A pancreatic hormone that raises blood glucose. Receptor-agonist claims for specific drugs are not made here.

Variation in the time between heartbeats. A wearable’s estimate needs its own validation study.

A laboratory separation method often used in purity testing. This glossary sets no pass-fail cutoff.

The desire disorder named in the VYLEESI labeling summarized on the bremelanotide page.

A U.S. FDA framework for studying a significant-risk device in people. Study details are not copied here.

A device or object placed inside the body. This wiki does not describe how to implant anything.

An FDA instruction to detain specified products at the border. Import Alert 66-80 has its own page.

A person’s agreement to an intervention or study after being told the relevant risks. Forms are not supplied here.

Electrodes that penetrate brain cortex. Channel counts and brand performance are not stated here.

How far a device enters the body. This wiki uses invasive, minimally invasive, and non-invasive as filing labels only.

Freeze-drying. This wiki does not give preparation steps for a lyophilized peptide.

A method that measures mass-to-charge ratios, often used to check identity. No acceptance rule is stated here.

A regulated product intended for diagnosis or treatment. Whether a gadget is a device depends on its claims and the law.

The receptor class named on the VYLEESI labeling for bremelanotide. Subtypes are not listed here.

Imagining a movement without performing it, a paradigm used in some EEG interfaces. Accuracy is not stated.

Using muscle electrical signals to command a prosthesis. Training steps are not described.

The identifier ClinicalTrials.gov assigns to a study record, in the form NCT followed by digits.

A training setup that shows a person a signal derived from their own nervous system. Benefit claims are not stated.

The International Neuromodulation Society’s definition is summarized on the neuromodulation page.

A device that replaces or assists a neural function. This glossary does not rank products.

A popular label for substances used in the hope of changing cognition. It is not a regulatory category on this page.

Use of an approved product for a purpose or population not in its labeling. This wiki does not recommend it.

An external device that supports a body part, as distinct from a prosthesis that replaces one.

Attachment of an implant to bone. Surgical technique is not described.

An event-related brain response used in some EEG spelling interfaces. Bit rates are not stated.

Classifying sensor signals to choose a prosthesis movement. Algorithms are not specified.

A short chain of amino acids. This wiki’s peptide pages do not provide doses or preparation steps.

The collection of safety reports after a product is in use. A report is not automatic proof of cause.

The U.S. FDA approval route for the highest-risk devices. A PMA number has to be checked on an FDA record.

A device that replaces a missing body part. WHO’s fact sheet names prosthetic limbs among assistive products.

The practice of recording personal data to understand one’s own life. The community site was not summarized.

A study that assigns participants to groups by chance. This wiki marks evidence grade A only when such a trial is the cited design.

A label some sellers put on products. The U.S. notes page records one FDA warning and is not a full legal opinion.

Heart rate measured at rest. A wearable’s resting-heart-rate feature needs its own validation.

A U.S. drug-compounding section of the Federal Food, Drug, and Cosmetic Act. The statute text was not pasted here.

The U.S. section covering outsourcing facilities that compound drugs. The statute text was not pasted here.

A cell state named as one of twelve hallmarks in the 2023 abstract on the hallmarks page.

A proposed approach aimed at senescent cells. No drug is recommended, and no result is stated in this glossary.

Electrical stimulation of the spinal cord, named by the International Neuromodulation Society as a neuromodulation example.

Steady-state visual evoked potential, a brain response to a flickering stimulus used in some EEG interfaces.

A name used by Synchron for an endovascular interface. Specifications are on the stub device page only as an outline.

A surgical rerouting of nerves to muscle so that EMG signals can drive a prosthesis. Technique is not described.

A weak electrical current passed across the scalp. Parameters and home setups are intentionally absent.

Stimulation of the brain with a magnetic coil. Cleared indications are not listed in this glossary.

TMS delivered as a train of pulses. Protocols are not described.

A patterned form of magnetic stimulation. Parameters are not stated.

Transcranial alternating current stimulation

Section titled “Transcranial alternating current stimulation”

An alternating current applied through scalp electrodes. Parameters are not stated.

Transcutaneous auricular vagus nerve stimulation

Section titled “Transcutaneous auricular vagus nerve stimulation”

Stimulation aimed at the vagus nerve through the skin of the ear. Device settings are not stated.

Stimulation of the vagus nerve, implanted or through the skin. Indications are not listed in this glossary.

An intracortical electrode array associated in public materials with Blackrock Neurotech. Specs are not copied.

A measure of maximal oxygen uptake during exercise. A watch estimate is not the laboratory measurement.

A device worn on the body that records or displays signals. Validation has to be read study by study.

A public FDA letter alleging violations. The letter itself is the source, not a wiki summary.

A U.S. FDA premarket notification used to claim a device is substantially equivalent to a predicate. A clearance is device-specific.

One of the twelve processes named in the PubMed 36599349 abstract, summarized on the hallmarks page.

Deregulated nutrient-sensing is one of the twelve hallmarks named in that abstract.

Protein homeostasis. Loss of proteostasis is one of the twelve hallmarks named in that abstract.

A disturbed microbiome, named as one of the twelve hallmarks in that abstract.

A product intended to act through genetic material. FDA’s cellular and gene therapy center is the U.S. starting point. Methods are not described.

A product made of cells. Clinic claims and preparation methods are not stated in this glossary.

A small near-field-communication tag some people place under the skin. Placement is not described.

Radio-frequency identification. Subdermal use is not instructed.

The document that states a fact: a paper, label, statute, or agency page. Wiki pages are not primary sources for each other.

A summary of a primary document. This wiki labels it as secondary and does not treat it as the underlying data.

Glucose in the fluid between cells, which many continuous monitors estimate. It is not identical to a laboratory blood glucose.

The implanted electronics that the International Neuromodulation Society says drive stimulation leads.

FDA’s list of bulk drug substances that may be used in compounding when statutory conditions are met. Being discussed is not the same as being listed.

A U.S. compounding facility registered under section 503B. Obligations are in the statute, which was not pasted here.

FDA’s program for reporting adverse events and product problems. The GLP-1 page points readers to it.

On Import Alert 66-80, FDA’s list of GLP-1 API manufacturers excluded from that alert’s detention recommendation. Firm names are not copied here.

The counter-ion attached to a drug substance. FDA says some semaglutide salts are not the approved active ingredient.

Page record

  • Type: Glossary
  • Domain: cross-cutting
  • Evidence: Not rated
  • Status: stub
  • Last reviewed: 2026-11-20

Stub, needs sourcing. This page does not yet contain enough checked facts to use as a reference.

Sources

No external sources are attached to this page.

Referenced by

A link from another wiki page is not evidence. Facts should point at the sources above.